Cargando…
ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
SIMPLE SUMMARY: Prostate cancer (PCa) is the second most diagnosed malignancy in men. PCa is a heterogeneous disease, with the clinical presentation ranging from localized and indolent to a rapidly progressing lethal metastatic disease, therefore, we needed the predictor to diagnosis of aggressive P...
Autores principales: | Oh, Jong Jin, Ho, Jin-Nyoung, Byun, Seok-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533922/ https://www.ncbi.nlm.nih.gov/pubmed/34680357 http://dx.doi.org/10.3390/cancers13205209 |
Ejemplares similares
-
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021) -
Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012) -
Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
por: Kim, Hwanik, et al.
Publicado: (2021) -
The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients
por: Oh, Jong Jin, et al.
Publicado: (2014) -
Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?
por: Kwon, Ohseong, et al.
Publicado: (2014)